Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Fidelman

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Techniques in Vascular and Interventional Radiology|November 29, 2015
Benign Biliary Strictures: Diagnostic Evaluation and Approaches to Percutaneous TreatmentNicholas Fidelman
Cardiovascular and Interventional Radiology|December 2, 2021
A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial ProtocolNicholas Fidelman
Cardiovascular and Interventional Radiology|March 11, 2022
Correction to: A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial ProtocolNicholas Fidelman
The Lancet. Oncology|March 1, 2020
Holmium-166 radioembolisation after peptide receptor radionuclide therapy: much needed data to help inform future researchNicholas Fidelman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2012
Pretransplant prediction of microvascular invasion in patients with hepatocellular carcinoma: added value of diffusion-weighted magnetic resonance imagingNicholas Fidelman, Aliya Qayyum
Current Treatment Options in Oncology|December 15, 2023
Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide TherapyRana Rabei, Nicholas Fidelman
Seminars in Interventional Radiology|December 17, 2020
Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide TherapyEvan D Lehrman, Nicholas Fidelman
AJR. American Journal of Roentgenology|September 24, 2015
Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage DiseaseNicholas Fidelman, Robert K Kerlan
Hepatology (Baltimore, Md.)|November 13, 2015
Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?Francis Y Yao, Nicholas Fidelman
Seminars in Interventional Radiology|March 18, 2024
Intra-arterial Peptide Receptor Radionuclide Therapy for the Treatment of Hepatic Neuroendocrine Tumor Metastases: Hope or Hype?Michael V Khanjyan, Nicholas Fidelman
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Techniques in Vascular and Interventional Radiology|November 29, 2015
Benign Biliary Strictures: Diagnostic Evaluation and Approaches to Percutaneous TreatmentNicholas Fidelman
Cardiovascular and Interventional Radiology|December 2, 2021
A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial ProtocolNicholas Fidelman
Cardiovascular and Interventional Radiology|March 11, 2022
Correction to: A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial ProtocolNicholas Fidelman
The Lancet. Oncology|March 1, 2020
Holmium-166 radioembolisation after peptide receptor radionuclide therapy: much needed data to help inform future researchNicholas Fidelman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2012
Pretransplant prediction of microvascular invasion in patients with hepatocellular carcinoma: added value of diffusion-weighted magnetic resonance imagingNicholas Fidelman, Aliya Qayyum
Current Treatment Options in Oncology|December 15, 2023
Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide TherapyRana Rabei, Nicholas Fidelman
Seminars in Interventional Radiology|December 17, 2020
Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide TherapyEvan D Lehrman, Nicholas Fidelman
AJR. American Journal of Roentgenology|September 24, 2015
Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage DiseaseNicholas Fidelman, Robert K Kerlan
Hepatology (Baltimore, Md.)|November 13, 2015
Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?Francis Y Yao, Nicholas Fidelman
Seminars in Interventional Radiology|March 18, 2024
Intra-arterial Peptide Receptor Radionuclide Therapy for the Treatment of Hepatic Neuroendocrine Tumor Metastases: Hope or Hype?Michael V Khanjyan, Nicholas Fidelman
Pageof 12